<span style="color: #222222;">Bharath Biotech Joint MD Suchitra llla has said that phase 3 trial of India's indigenous Coronavirus vaccine Covaxin is progressing well. Speaking exclusively to AIR Correspondent, she said 26,000 volunteers across the country are currently undergoing the trial.</span><br />” <br />” <span style="color: #222222;">She also stated that this is a two-dose vaccine.</span><br />” <br />” &nbsp;